Smith & Nephew : Encouraging first quarter, guidance confirmed
>Beat of expectations - Smith & Nephew published its Q1 trading report today. Q1 revenues of $1,306m (+3.3% y-o-y) were 3% ahead of our expectations 2% ahead of consensus. The underlying growth in the quarter was 5.9%, which was a beat of our 3.4% and consensus’ 2.8%. There was no external growth effect. The forex environment provided a headwind of 260bp, in line with expectations. No bottom line is reported on a quarterly basis. Encouraging quarter for ...Smith & Nephew is a global medical devices business operating in the markets for advanced surgical devices comprising orthopaedic reconstruction and trauma, sports medicine and advanced wound management. Co.'s advanced medical products and services include: Orthopaedic Reconstruction and Trauma (joint replacement systems for knees and hips and products to help repair broken bones); Advanced Wound Management (treatment and prevention products for hard-to-heal wounds); and Sports Medicine (implants and enabling technologies for minimally invasive repair of the joint).
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.